In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Sebastián Scioli-MontotoLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata 1900, Argentina.ORCID 0000-0003-3314-3406 Martin LobosLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata 1900, Argentina.ORCID 0009-0000-0834-1027 Mauricio MelisLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata 1900, Argentina.ORCID 0000-0002-3295-6491 Santiago RuattaLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata 1900, Argentina.ORCID 0000-0003-3064-0378 Giuliana MuracaLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata 1900, Argentina.ORCID 0000-0002-4785-8050 Cecilia Yamil ChainConsejo Nacional de Investigaciones Científicas y Técnicas (CONICET), CCT, La Plata 1900, Argentina.ORCID 0000-0002-8234-0556 Sebastián CisnerosInstituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA-CONICET-UNLP), La Plata 1900, Argentina.ORCID 0000-0001-7563-978X Vera Alejandra AlvarezConsejo Nacional de Investigaciones Científicas y Técnicas (CONICET), CCT, La Plata 1900, Argentina.ORCID 0000-0002-4909-4592 German IslanConsejo Nacional de Investigaciones Científicas y Técnicas (CONICET), CCT, La Plata 1900, Argentina.ORCID 0000-0002-3275-1349 Alan TaleviLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata 1900, Argentina.ORCID 0000-0003-3178-826X María Esperanza RuizLaboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata 1900, Argentina.ORCID 0000-0001-8617-667X Funding
ApoyoDravet no numberNational Agency for the Promotion of Research, Technological Development and Innovation Agencia I+D+I, PICT 2019-01075National University of La Plata 11/X1022
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cannabidiolDravet syndromelipid nanoparticlesnanostructured lipid carriersoral administrationpediatric formulationspharmacokinetic studyrelease profileresponse surfacestiripentol
Identifiers
PMID42076153
PMCPMC13118642
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390